The study team has already secured a patent on their technique in the country.

Elaborating on the new method, John said: 'Since we are using the patient's own bone marrow, no ethical issues are involved. Moreover there will be no chance of adverse reactions or rejection reactions. The neurotransmitter combination that is used to modulate the bone marrow is naturally occurring amines in our system and hence will not produce any untoward effects.'

The study team has secured written consent from hundreds of patients willing to undergo the clinical trials using the new technique.

Speaking to IANS, 27-year-old George K. Thomas, who has been bed-ridden after a road accident in 2007, said: 'I have tried various treatments and there is no change. I am prepared to go through the clinical trials of this new technique. I really wish they get the sanction for the trials.'